lipomatosis: an autosomal dominant condition in which multiple lipomas are present on the body. Many discrete, encapsulated lipomas form on the trunk and extremities, with relatively few on the head and shoulders.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
98 |
4. Check minimum number of eventsNone |
98 |
5. Include endpointsNone |
98 |
6. Filter based on genotype QC (FinnGen only) |
98 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E88
- Name in latin
- Lipomatosis non alibi classificata
Similar endpoints
↥List of similar endpoints to
Lipomatosis, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other metabolic disorders
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 515 | 278 | 233 |
| Only index persons | 487 | 269 | 218 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 53.98 | 54.63 | 53.59 |
| Only index persons | 54.26 | 54.83 | 53.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 98 | 59 | 39 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 56.26 | 57.23 | 54.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 85
- Matched controls
- 850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E88.2
ICD-10 Finland
Lipomatosis, not elsewhere classified
+∞
120.4
85
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
13.7
9.0
15
13
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
24.9
8.2
11
5
M48.0
ICD-10 Finland
Spinal stenosis
6.6
8.1
21
40
N03AX12
ATC
gabapentin; oral
4.9
7.7
27
74
N03AX16
ATC
pregabalin; oral
4.0
7.3
33
115
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
43.6
6.9
8
*
N02AX02
ATC
tramadol; systemic, rectal
3.4
6.8
50
253
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.2
6.4
17
33
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.8
6.2
29
102
R5140
NOMESCO Finland
Monitoring the use of the aid
5.1
6.1
19
45
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
48
203
3.67
9.21
3.6
3.0
ng/l
946.7
967.2
0.02
43
176
(3012516) Albumin [Mass/volume] in Urine
45
211
3.09
6.90
3.9
2.9
mg/l
90.8
335.5
0.36
32
133
(3009508) Creatinine [Moles/volume] in Urine
45
219
2.95
6.36
3.9
2.8
mmol/l
7.7
7.7
0.00
39
185
(3013115) Eosinophils [#/volume] in Blood
67
412
2.98
6.01
8.0
5.2
e9/l
0.2
0.2
0.80
55
373
(3020682) Albumin/Creatinine [Ratio] in Urine
45
226
2.83
5.91
4.6
3.6
mg/mmol
15.0
5.3
0.38
34
141
(42870588) Differential panel, method unspecified - Blood
48
250
2.80
5.88
7.1
4.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
65
400
2.86
5.70
7.5
5.1
e9/l
0.6
0.5
1.52
51
352
(3006315) Basophils [#/volume] in Blood
65
402
2.83
5.61
7.5
5.1
e9/l
0.0
0.0
1.09
51
355
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
36
168
2.81
5.34
1.9
1.6
mg/l
1.0
0.9
0.12
30
126
(3019198) Lymphocytes [#/volume] in Blood
65
412
2.72
5.19
7.6
5.1
e9/l
1.9
1.8
0.25
52
373
(3022313) Gas panel - Capillary blood
12
30
4.42
4.58
5.4
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
75
537
2.69
4.26
6.9
3.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
22
88
2.93
4.24
2.3
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
67
464
2.40
3.95
11.2
9.8
e9/l
4.7
3.8
2.44
56
413
(3032080) INR in Blood by Coagulation assay
45
265
2.29
3.87
11.9
6.1
inr
1.1
1.2
0.08
11
87
(40760888) Immunoglobulin light chains.free panel - Serum
8
12
7.14
3.75
1.1
5.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
62
421
2.29
3.75
8.1
5.7
umol/l
9.0
11.0
2.36
62
398
(3023368) Bacteria identified in Blood by Culture
34
181
2.35
3.67
6.3
3.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
79
599
2.64
3.66
5.4
3.8
pmol/l
14.3
14.8
1.01
71
543
(40758558) Short blood count panel - Blood
35
189
2.33
3.65
8.2
6.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
38
215
2.25
3.54
5.1
2.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
54
353
2.18
3.51
10.5
5.1
mmol/l
1.2
1.2
0.16
48
296
(40768804) Tissue Pathology biopsy report
51
335
2.09
3.18
1.8
2.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
45
282
2.10
3.18
2.3
1.7
pmol/l
98.6
100.5
0.10
25
135
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
161
2.24
3.12
1.1
1.2
iu/ml
16.9
35.0
—
6
46
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
76
2.68
3.11
3.6
3.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
13
47
3.04
2.95
17.5
5.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
92
797
3.52
2.94
6.0
4.3
mmol/l
6.3
5.9
1.82
87
741
(3021901) Oxygen saturation in Capillary blood
6
9
7.01
2.91
5.0
2.9
—
—
—
0
0
(3026782) Osmolality of Urine
25
130
2.24
2.78
5.3
2.4
mosm/kgh2o
564.1
557.7
0.05
20
105
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
32
3.37
2.73
10.3
5.6
mmol/l
24.6
25.3
—
10
32
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
90
775
2.97
2.71
21.9
11.3
ml/min/173m2
79.9
82.3
0.37
80
632
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
38
3.13
2.68
1.4
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
36
220
2.01
2.63
4.1
3.3
ph
7.4
7.4
—
8
50
(3012544) pH of Venous blood
13
51
2.79
2.56
8.3
3.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
22
112
2.24
2.56
2.5
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
45
2.90
2.56
1.4
1.5
—
—
—
0
0
(1002224) Polysomnography panel
12
45
2.90
2.56
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
16
4.62
2.52
1.3
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
77
619
2.14
2.47
9.9
6.7
u/l
78.6
75.8
0.43
77
577
(3000850) Epithelial cells [#/volume] in Urine
27
153
2.06
2.40
4.6
2.5
e6/l
5.8
4.8
0.38
22
136
(3024928) Oxygen saturation in Venous blood
5
8
6.51
2.40
12.0
4.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
20
103
2.18
2.25
1.2
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
32
199
1.90
2.17
7.6
2.7
e6/l
0.3
0.5
0.29
26
146
(3044889) 12 lead EKG panel
71
571
1.88
2.06
4.6
3.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
21
3.51
2.00
3.0
2.4
—
—
—
0
0
(3000492) Spirometry study
14
65
2.35
1.99
1.9
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
21
116
2.03
1.98
6.8
2.3
e6/l
2.2
0.8
0.56
14
73
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
41
283
1.77
1.97
3.7
3.2
ng/l
93.9
30.3
0.42
31
184
(3035350) Ketones [Presence] in Urine by Test strip
52
385
1.75
1.96
5.6
3.3
estimate
0.0
0.0
0.00
11
83
(3044640) Blood type and Crossmatch panel - Blood
33
214
1.82
1.95
3.1
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
16
80
2.20
1.93
2.2
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
19
102
2.07
1.93
7.4
2.5
e6/l
4.2
2.8
0.17
12
60
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
22
3.34
1.92
1.9
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
40
2.67
1.90
1.8
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
31
200
1.80
1.85
6.9
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
24
3.06
1.76
1.4
1.5
g/l
0.3
0.2
—
7
24
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
76
2.15
1.75
1.9
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
23
137
1.89
1.75
1.8
1.6
nmol/l
1163.2
1272.1
0.23
17
103
(3004588) Protein electrophoresis panel - Serum or Plasma
10
42
2.54
1.74
1.2
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
52
394
1.68
1.73
5.7
3.3
estimate
0.0
0.0
0.00
11
80
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
33
221
1.74
1.73
1.7
1.7
mmol/l
2.1
1.3
1.71
27
179
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
162
1.82
1.72
6.0
3.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
15
77
2.12
1.70
9.7
6.1
mmol/l
2.3
1.6
—
10
67
(3021589) Normoblasts [#/volume] in Blood
49
367
1.67
1.70
13.1
8.9
e9/l
0.0
0.0
0.45
39
299
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
25
2.93
1.68
1.4
1.5
g/l
1.3
1.1
—
7
25
(3007164) IgA [Mass/volume] in Serum or Plasma
24
147
1.84
1.68
1.7
1.3
g/l
1.9
2.4
1.54
13
90
(3021601) Nitrite [Presence] in Urine by Test strip
51
388
1.66
1.65
8.2
4.3
estimate
0.0
0.0
0.00
11
80
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
26
165
1.78
1.62
2.7
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
37
260
1.68
1.61
7.1
2.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
26
2.82
1.61
1.1
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
15
3.45
1.54
1.4
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
11
52
2.26
1.51
1.4
3.1
e9/l
62.5
66.0
—
6
41
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
12
59
2.18
1.51
3.9
2.5
ml/min/173m2
68.6
71.3
—
5
25
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
82
1.98
1.45
2.3
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
82
1.98
1.45
1.9
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
15
83
1.95
1.40
2.0
1.7
—
—
—
0
0
(3019225) pH of Specimen
13
69
2.02
1.36
7.8
3.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
83
735
1.84
1.36
26.0
11.4
%
40.0
40.5
0.18
62
549
(3018677) aPTT in Platelet poor plasma by Coagulation assay
16
92
1.88
1.35
2.6
1.8
s
29.4
29.3
0.02
16
87
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
24
2.59
1.32
1.5
1.8
nmol/l
27.2
42.9
—
6
24
(3002582) Erythrocytes [#/volume] in Urine
31
221
1.59
1.24
8.0
2.9
e6/l
13.9
337.4
0.58
26
171
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
23
152
1.67
1.23
1.1
1.2
u/ml
0.7
3.0
—
5
59
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
45
350
1.53
1.23
4.4
3.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
18
111
1.76
1.23
3.1
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
23
153
1.66
1.20
1.9
1.8
pmol/l
371.0
461.0
1.35
17
135
(3018095) Leukocytes [#/volume] in Urine
35
262
1.52
1.12
9.2
3.4
e6/l
58.9
45.5
0.13
28
188
(3002256) Pathology report gross observation
18
114
1.71
1.12
1.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
41
2.03
1.11
1.4
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
22
2.34
1.04
1.4
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
91
851
1.97
0.96
20.0
10.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.22
0.93
2.7
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
28
2.22
0.93
2.7
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
29
2.14
0.91
8.5
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
87
808
1.68
0.83
25.0
11.6
mg/l
22.7
21.1
0.21
82
621
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
39
314
1.40
0.83
5.3
3.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
27
0.00
0.78
0.0
5.1
—
1.1
—
0
27
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
34
1.81
0.77
18.5
6.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
24
2.14
0.75
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
38
1.91
0.75
4.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
25
2.05
0.74
2.8
2.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
5
26
1.97
0.71
1.6
2.9
mg/l
8.6
10.2
—
5
26
(3013512) EKG study
30
237
1.38
0.70
5.5
3.0
—
—
—
0
0
(4010399)
10
63
1.65
0.64
2.1
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
30
1.70
0.62
2.0
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
115
1.47
0.61
2.4
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
52
1.59
0.61
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
37
1.66
0.56
10.5
2.1
g/l
119.5
134.2
—
6
37
(40760892) CBC W Ordered Manual Differential panel - Blood
25
199
1.34
0.55
7.2
4.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
40
1.53
0.52
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
28
229
1.31
0.52
4.6
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
27
223
1.29
0.46
5.5
3.7
estimate
0.0
0.0
—
10
79
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
50
1.43
0.46
1.6
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
31
1.64
0.43
1.8
1.7
mmol/l
26.2
24.7
—
5
31
(40761535) Cells panel - Urine sediment
8
58
1.41
0.43
4.0
3.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
33
1.54
0.42
12.2
1.7
%
1.1
1.8
—
5
33
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
9
66
1.40
0.40
4.7
4.2
mmol/l
1.2
1.2
—
9
59
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
36
1.41
0.39
3.2
1.4
—
—
—
0
0
(4035726)
9
69
1.33
0.38
1.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
54
494
1.21
0.36
2.8
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
187
0.77
0.36
5.3
4.2
%
21.9
21.6
—
6
89
(40761536) Microorganisms panel - Urine sediment
10
73
1.41
0.36
5.7
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
88
0.66
0.34
2.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
75
1.37
0.31
1.7
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
87
1.30
0.25
1.2
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
37
1.37
0.24
23.6
5.3
%
93.2
92.9
—
5
37
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
38
1.33
0.23
23.6
5.1
%
0.5
0.7
—
5
38
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
39
1.30
0.23
23.6
5.1
%
1.4
1.8
—
5
39
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
42
1.20
0.22
3.0
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
23
203
1.17
0.21
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
11
0.00
0.21
0.0
1.1
—
0.9
—
0
11
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
3.1
—
0
12
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
0.9
—
0
6
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
23.0
—
0
12
(3019060) Gas panel - Arterial blood
6
49
1.24
0.20
1.8
3.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
58
1.22
0.18
4.6
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
94
1.19
0.13
10.9
7.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
63
0.78
0.08
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
68
1.03
0.08
1.7
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
74
1.09
0.08
1.7
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
81
0.85
0.07
1.9
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
15
138
1.10
0.07
1.8
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
309
1.05
0.04
3.3
2.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
127
0.94
0.02
1.3
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
1.4
—
13.4
—
0
8
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.3
—
0.6
—
0
8
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
1.7
—
0
6
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.0
—
6.0
—
0
6
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
1.0
—
4.0
—
0
7
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
0.9
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
12.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
136.6
—
0
5
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
55.9
—
0
7
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
26.1
—
0
6
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
12.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.3
—
198.0
—
0
7
(3002385) Erythrocyte distribution width [Ratio]
68
680
1.00
0.00
33.6
14.1
%
14.0
13.7
0.48
68
671
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
1.0
—
107.0
—
0
7
(3020491) Glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
7.3
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_LIPOMATOSIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have E4_LIPOMATOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: E4_LIPOMATOSIS – Lipomatosis, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data